Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
ResMed (RMD UN)
Watchlist
23
Analysis
Health Care
•
United States
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Resmed Inc
•
20 Sep 2023 04:00
ResMed Inc.: Will The Acquisition of Somnoware Up The Respiratory Diagnostics Game? - Major Drivers
ResMed Inc. delivered a disappointing set of results as the company was unable to meet the revenue and earnings expectations of Wall Street. Group...
Baptista Research
Follow
361 Views
Share
bullish
•
Resmed Inc
•
27 May 2023 01:47
ResMed Inc.: On Track to Meet Global Demand for Connected CPAP and APAP Devices – Key Drivers
ResMed delivered a strong set of financial results in the last quarter and managed an all-around beat. While they are still addressing some supply...
Baptista Research
Follow
535 Views
Share
bullish
•
Resmed Inc
•
02 Apr 2023 02:15
ResMed Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report
ResMed is a leading medical technology player that specializes in the treatment of sleep apnea and other respiratory disorders. Globally, the...
Baptista Research
Follow
468 Views
Share
bullish
•
Resmed Inc
•
02 Apr 2023 02:14
ResMed Inc.: Initiation of Coverage – Recent Acquisitions & Other Key Drivers
This is our first report on ResMed, a leading medical equipment company that specializes in the treatment of sleep apnea and other respiratory...
Baptista Research
Follow
518 Views
Share
bullish
•
Siemens Healthineers
•
05 Aug 2020 20:06
Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer
This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...
Janaghan Jeyakumar, CFA
Follow
710 Views
Share
First
Previous
13
14
15
16
17
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x